Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms

Metastatic breast cancer (mBC) is responsible for >90% of breast cancer-related deaths. Microtubule-targeting agents (MTAs) are the front-line treatment for mBC. However, the effectiveness of MTAs is frequently limited by the primary or acquired resistance. Furthermore, recurrent mBC derived from...

Descripción completa

Detalles Bibliográficos
Autores principales: Graff, Brendan T., Palanivel, Chitra, Jenkins, Christopher B., Baranowska-Kortylewicz, Janina, Yan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183037/
https://www.ncbi.nlm.nih.gov/pubmed/37179350
http://dx.doi.org/10.1038/s41420-023-01454-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183037/
https://www.ncbi.nlm.nih.gov/pubmed/37179350
http://dx.doi.org/10.1038/s41420-023-01454-6

Ejemplares similares